Keywords: ligand, earns, 5m, lilly, milestone, nasdaq-listed, pharmaceuticals

Ligand earns $1.5M from Lilly milestone

Article | 31 March 2003

Print This

Nasdaq-listed Ligand Pharmaceuticals says that it has earned $1.5million via a milestone payment from Eli Lilly. The consideration relates to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in